Desk›Healthcare› Vanta Bioscience Ltd
Vanta Bioscience Ltd
BSE 540729 · NSE VANTABIO · ISIN INE695X01011 · Group MT · Active
Healthcare › Healthcare › Healthcare Services › Healthcare Research, Analytics & Technology
Disclosure profile 4 filings in the window
| Tag | Filings |
|---|---|
| Procedural | |
| AGM / EGM | 2 |
| Annual Report | 1 |
| Trading Window | 1 |
| Procedural sub-total | 4 |
| Total | 4 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group MT, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
4 filings · 0 selected · busiest 2026-09-30
Filing rhythm · the twelve most recent
2026-09-232026-09-30
SelectedProcedural
Filings
4 in the window
-
30 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Submission of AGM Proceedings, Voting Results and Scrutinizers Report for the 10th Annual General Meeting
AGM/EGM / AGM View filing →
-
30 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Submission of AGM Proceedings, Voting Results and Scrutinizer's Report for the 10th AGM
AGM/EGM / AGM View filing →
-
29 September 2026 ·
Closure of Trading Window
Closure of Trading Window
Insider Trading / SAST / Closure of Trading Window View filing →
-
23 September 2026 ·
Reg. 34 (1) Annual Report.
Annual Report for FY 2025-26
Others / Reg. 34 (1) Annual Report View filing →
RSS feed for Vanta Bioscience Ltd · the 50 most recent filings